Top Drug Discovery Companies
241 Drug Discovery companies, sorted by total funding raised.

Precision oncology biotech developing first-in-class therapeutics targeting post-translational mo...
AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long t...
Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...
Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...
A versatile integrin-binding peptide, PIP
AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for ...
Provides antibody discovery and engineering services to biopharma partners using a yeast-based pl...
Generative AI platform for accelerated drug discovery and molecule design serving pharma and biot...

Medicinal Chemistry powered by Machine Learning

Make undruggable targets a thing of the past
Discovering drugs that target the DNA regulome
Biotechnology company developing AI-designed Antibody Cages (AbCs), a novel class of biologics th...
Biotechnology company developing first-in-class small molecule GPR35 inhibitors to treat ulcerati...
R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

The next generation of induced-proximity medicines.
Next-generation biocides for sustainable agriculture at scale

Biotechnology company developing advanced therapies for autoimmune and inflammatory diseases.

Global preclinical research and clinical specialty testing provider driving excellence in oncolog...

Developer of programmable mRNA delivery technology to diverse cell types in the body; next-genera...
Empowering women. Period.
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
We're building fully automated labs for protein engineering
Bioactive membranes and other separation technologies for the chemical processing and pharmaceuti...
Delivering RNA therapies.